Related Experiment Video
Updated: Oct 6, 2025
09:10
An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
Published on: November 15, 2024
592
Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Brainstem Pathologies
Purvee D Patel1, Omar Ashraf2, Shabbar F Danish3
1Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
World Neurosurgery
|January 16, 2022
Summary
Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) offers a minimally invasive approach for brainstem pathologies. However, this study highlights significant risks, including high morbidity and mortality, necessitating careful patient selection.
Area of Science:
- Neurosurgery
- Oncology
- Minimally Invasive Procedures
Background:
- Deep-seated brainstem pathologies pose significant treatment challenges.
- Traditional open surgery may not offer safe corridors for intervention.
- Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) presents a less invasive alternative.
Purpose of the Study:
- To evaluate the safety and efficacy of MRgLITT for brainstem pathologies.
- To analyze outcomes and complications associated with MRgLITT in this specific anatomical region.
Main Methods:
- Retrospective analysis of 12 patients undergoing MRgLITT for brainstem lesions (2011-2020).
- Procedures involved stereotactic laser placement followed by real-time MRI-guided ablation.
- Data collected included demographics, operative parameters, and complications.
Main Results:
- MRgLITT was performed on 12 patients (average age 47.6 years) for primary and metastatic tumors.
- Average ablation volume was 2.4 cm³, with ablation times around 324 seconds.
- One perioperative mortality and 7 postoperative deficits were recorded; 2 patients experienced recurrence.
Conclusions:
- The brainstem is a challenging area for even minimally invasive treatments like MRgLITT.
- High rates of morbidity and mortality underscore the need for careful assessment of potential benefits versus risks.
- Outcomes must be judiciously evaluated given the complexities of treating brainstem pathologies.
